Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Wu-Chou Su
2016
81 Citations (Scopus)

A randomized phase 2 study comparing the combination of ficlatuzumab and gefitinib with gefitinib alone in asian patients with advanced stage pulmonary adenocarcinoma

Mok, T. S. K., Geater, S. L., Su, W. C., Tan, E. H., Yang, J. C. H., Chang, G. C., Han, M., Komarnitsky, P., Payumo, F., Garrus, J. E., Close, S. & Park, K., 2016, In : Journal of Thoracic Oncology. 11, 10, p. 1736-1744 9 p.

Research output: Contribution to journalArticle

24 Citations (Scopus)
7 Citations (Scopus)

Elucidating Quantum Confinement in Graphene Oxide Dots Based on Excitation-Wavelength-Independent Photoluminescence

Yeh, T. F., Huang, W. L., Chung, C. J., Chiang, I. T., Chen, L. C., Chang, H. Y., Su, W. C., Cheng, C., Chen, S. J. & Teng, H., 2016 Jun 2, In : Journal of Physical Chemistry Letters. 7, 11, p. 2087-2092 6 p.

Research output: Contribution to journalArticle

75 Citations (Scopus)

Epidermal growth factor receptor mutation and anaplastic lymphoma kinase gene fusion: Detection in malignant pleural effusion by RNA or PNA analysis

Chen, Y. L., Lee, C. T., Lu, C. C., Yang, S. C., Chen, W. L., Lee, Y. C., Yang, C. H., Peng, S. L., Su, W. C., Chow, N. H. & Ho, C. L., 2016 Jun, In : PloS one. 11, 6, e0158125.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Fanconi anemia genes in lung adenocarcinoma - A pathway-wide study on cancer susceptibility

Yang, S. Y., Hsiung, C. N., Li, Y. J., Chang, G. C., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Yang, P. C., Chen, C. J., Wu, P. E., Yu, J. C., Shen, C. Y. & Hsu, H. M., 2016 Feb 3, In : Journal of biomedical science. 23, 1, 23.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Handheld energy-efficient magneto-optical real-time quantitative PCR device for target DNA enrichment and quantification

Li, T. J., Chang, C. M., Chang, P. Y., Chuang, Y. C., Huang, C. C., Su, W. C. & Shieh, D. B., 2016 Jun 3, In : NPG Asia Materials. 8, 6, e277.

Research output: Contribution to journalArticle

14 Citations (Scopus)
7 Citations (Scopus)

Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women

Wang, Z., Seow, W. J., Shiraishi, K., Hsiung, C. A., Matsuo, K., Liu, J., Chen, K., Yamji, T., Yang, Y., Chang, I. S., Wu, C., Hong, Y. C., Burdett, L., Wyatt, K., Chung, C. C., Li, S. A., Yeager, M., Hutchinson, A., Hu, W., Caporaso, N. & 130 others, Landi, M. T., Chatterjee, N., Song, M., Fraumeni, J. F., Kohno, T., Yokota, J., Kunitoh, H., Ashikawa, K., Momozawa, Y., Daigo, Y., Mitsudomi, T., Yatabe, Y., Hida, T., Hu, Z., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Yin, Z., Li, X., Ren, Y., Guan, P., Chang, J., Tan, W., Chen, C. J., Chang, G. C., Tsai, Y. H., Su, W. C., Chen, K. Y., Huang, M. S., Chen, Y. M., Zheng, H., Li, H., Cui, P., Guo, H., Xu, P., Liu, L., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Jiang, G., Fei, K., Park, J. Y., Kim, Y. H., Sung, J. S., Park, K. H., Kim, Y. T., Jung, Y. J., Kang, C. H., Park, I. K., Kim, H. N., Jeon, H. S., Choi, J. E., Choi, Y. Y., Kim, J. H., Oh, I. J., Kim, Y. C., Sung, S. W., Kim, J. S., Yoon, H. I., Kweon, S. S., Shin, M. H., Seow, A., Chen, Y., Lim, W. Y., Liu, J., Wong, M. P., Lee, V. H. F., Bassig, B. A., Tucker, M., Berndt, S. I., Chow, W. H., Ji, B. T., Wang, J., Xu, J., Sihoe, A. D. L., Ho, J. C. M., Chan, J. K. C., Wang, J. C., Lu, D., Zhao, X., Zhao, Z., Wu, J., Chen, H., Jin, L., Wei, F., Wu, G., An, S. J., Zhang, X. C., Su, J., Wu, Y. L., Gao, Y. T., Xiang, Y. B., He, X., Li, J., Zheng, W., Shu, X. O., Cai, Q., Klein, R., Pao, W., Lawrence, C., Hosgood, H. D., Hsiao, C. F., Chien, L. H., Chen, Y. H., Chen, C. H., Wang, W. C., Chen, C. Y., Wang, C. L., Yu, C. J., Chen, H. L., Su, Y. C., Tsai, F. Y., Chen, Y. S., Li, Y. J., Yang, T. Y., Lin, C. C., Yang, P. C., Wu, T., Lin, D., Zhou, B., Yu, J., Shen, H., Kubo, M., Chanock, S. J., Rothman, N. & Lan, Q., 2016 Feb 1, In : Human Molecular Genetics. 25, 3, p. 620-629 10 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)

Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer

Jen, J., Lin, L. L., Chen, H. T., Liao, S. Y., Lo, F. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2016 May 5, In : Oncogene. 35, 18, p. 2357-2369 13 p.

Research output: Contribution to journalArticle

24 Citations (Scopus)

Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer

Scagliotti, G., Kang, J. H., Smith, D., Rosenberg, R., Park, K., Kim, S. W., Su, W. C., Boyd, T. E., Richards, D. A., Novello, S., Hynes, S. M., Myrand, S. P., Lin, J., Smyth, E. N., Wijayawardana, S., Lin, A. B. & Pinder-Schenck, M., 2016 Oct 1, In : Investigational New Drugs. 34, 5, p. 625-635 11 p.

Research output: Contribution to journalArticle

28 Citations (Scopus)

Positive feedback regulation between IL10 and EGFR promotes lung cancer formation

Hsu, T. I., Wang, Y-C., Hung, C. Y., Yu, C. H., Su, W-C., Chang, W. C. & Hung, J-J., 2016 Apr 12, In : Oncotarget. 7, 15, p. 20840-20854 15 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)

Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs

Hwu, J. R., Tsay, S. C., Chuang, K. S., Kapoor, M., Lin, J. Y., Yeh, C. S., Su, W. C., Wu, P. C., Tsai, T. L., Wang, P. W. & Shieh, D. B., 2016 Feb 5, In : Chemistry - A European Journal. 22, 6, p. 1926-1930 5 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy

Wang, Y-C., Wang, S. A., Chen, P. H., Hsu, T. I., Yang, W. B., Chuang, Y. P., Su, W-C., Liaw, H-J., Chang, W. C. & Hung, J-J., 2016 Jul 14, In : Oncogene. 35, 28, p. 3669-3680 12 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)

De Santis, M., Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W. C., Albiges, L., Lin, C. C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N. & Culine, S., 2016 Mar 1, In : Annals of Oncology. 27, 3, p. 449-454 6 p., mdv609.

Research output: Contribution to journalArticle

33 Citations (Scopus)
2017

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Ahn, M. J., Kim, D. W., Cho, B. C., Kim, S. W., Lee, J. S., Ahn, J. S., Kim, T. M., Lin, C. C., Kim, H. R., John, T., Kao, S., Goldman, J. W., Su, W. C., Natale, R., Rabbie, S., Harrop, B., Overend, P., Yang, Z. & Yang, J. C. H., 2017 Nov, In : The Lancet Respiratory Medicine. 5, 11, p. 891-902 12 p.

Research output: Contribution to journalArticle

38 Citations (Scopus)

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Seow, W. J., Matsuo, K., Hsiung, C. A., Shiraishi, K., Song, M., NamKim, H., Wong, M. P., Hong, Y. C., Dean Hosgood, H., Wang, Z., Chang, I. S., Wang, J. C., Chatterjee, N., Tucker, M., Wei, H., Mitsudomi, T., Zheng, W., Kim, J. H., Zhou, B., Caporaso, N. E. & 166 others, Albanes, D., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Shu, X. O., Kim, Y. C., Bassig, B. A., Chang, J., Man Ho, J. C., Ji, B. T., Kubo, M., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Nokihara, H., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Yin, Z., Shi, J., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wu, T., Wei, F., Wong, J. Y. Y., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Lee, V. H. F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Yang, P. C., Lin, H. C., Xiang, Y. B., Seow, A., Park, J. Y., Kweon, S. S., Chen, C. J., Li, H., Gao, Y. T., Wu, C., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Lawrence, C., Burdett, L., Yeager, M., Jacobs, K. B., Hutchinson, A., Berndt, S. I., He, X., Wu, W., Wang, J., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Hu, L., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Loon Sihoe, A. D., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Cai, Q., Lin, C. C., Park, I. K., Xu, P., Dong, J., Kim, C., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Chan, J. K. C., Chu, M., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Lo, Y. L., Chen, Y. H., Fraumeni, J. F., Liu, J., Yamaji, T., Yang, Y., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Jiang, G., Fei, K., Wu, G., Chien, L. H., Chen, H. L., Su, Y. C., Tsai, F. Y., Chen, Y. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Lin, D., Chen, K., Wu, Y. L., Landi, M. T., Shen, H., Rothman, N., Kohno, T., Chanock, S. J. & Lan, Q., 2017, In : Human Molecular Genetics. 26, 2, p. 454-465 12 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)
13 Citations (Scopus)

Cabozantinib in hepatocellular carcinoma: Results of a phase 2 placebo-controlled randomized discontinuation study

Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T. S., Su, W. C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y. & Van Cutsem, E., 2017, In : Annals of Oncology. 28, 3, p. 528-534 7 p.

Research output: Contribution to journalArticle

58 Citations (Scopus)

Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer

Lu, C. S., Shieh, G. S., Wang, C. T., Su, B. H., Su, Y. C., Chen, Y. C., Su, W. C., Wu, P., Yang, W. H., Shiau, A. L. & Wu, C. L., 2017, In : Oncotarget. 8, 19, p. 30844-30858 15 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways

Su, W. P., Ho, Y. C., Wu, C. K., Hsu, S. H., Shiu, J. L., Huang, J. C., Chang, S. B., Chiu, W. T., Hung, J. J., Liu, T. L., Wu, W. S., Wu, P. Y., Su, W. C., Chang, J. Y. & Liaw, H., 2017 Dec 1, In : Scientific reports. 7, 1, 3879.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan

Yang, S. C., Lai, W. W., Lin, C. C., Su, W. C., Ku, L. J., Hwang, J. S. & Wang, J. D., 2017 Jun 1, In : Lung Cancer. 108, p. 183-191 9 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)

Dysregulation of Rab37-mediated cross-talk between cancer cells and endothelial cells via thrombospondin-1 promotes tumor neovasculature and metastasis

Tzeng, H. T., Tsai, C. H., Yen, Y. T., Cheng, H. C., Chen, Y. C., Pu, S. W., Wang, Y. S., Shan, Y. S., Tseng, Y. L., Su, W. C., Lai, W. W., Wu, L. W. & Wang, Y. C., 2017 May 1, In : Clinical Cancer Research. 23, 9, p. 2335-2345 11 p.

Research output: Contribution to journalArticle

24 Citations (Scopus)

EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis

Wang, S. A., Wang, Y. C., Chuang, Y. P., Huang, Y. H., Su, W. C., Chang, W. C. & Hung, J. J., 2017 May 25, In : Oncogene. 36, 21, p. 2930-2945 16 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer (Oncogene (2016) 35 18 (2357-2369))

Jen, J., Lin, L. L., Lo, F. Y., Chen, H. T., Liao, S. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2017 Aug 1, In : Oncogene. 36, 31, 1 p.

Research output: Contribution to journalComment/debate

Open Access

Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors

Chang, I. S., Jiang, S. S., Yang, J. C. H., Su, W. C., Chien, L. H., Hsiao, C. F., Lee, J. H., Chen, C. Y., Chen, C. H., Chang, G. C., Wang, Z., Lo, F. Y., Chen, K. Y., Wang, W. C., Chen, Y. M., Huang, M. S., Tsai, Y. H., Su, Y. C., Hsieh, W. S., Shih, W. C. & 8 others, Shieh, S. H., Yang, T. Y., Lan, Q., Rothman, N., Chen, C. J., Chanock, S. J., Yang, P. C. & Hsiung, C. A., 2017 Mar 1, In : American Journal of Respiratory and Critical Care Medicine. 195, 5, p. 663-673 11 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Liquid biopsy genotyping in lung cancer: Ready for clinical utility?

Huang, W. L., Chen, Y. L., Yang, S. C., Ho, C. L., Wei, F., Wong, D. T., Su, W. C. & Lin, C. C., 2017 Jan 1, In : Oncotarget. 8, 11, p. 18590-18608 19 p.

Research output: Contribution to journalArticle

28 Citations (Scopus)

Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial

Thress, K. S., Jacobs, V., Angell, H. K., Yang, J. C. H., Sequist, L. V., Blackhall, F., Su, W. C., Schuler, M., Wolf, J., Gold, K. A., Cantarini, M., Barrett, J. C. & Jänne, P. A., 2017 Oct, In : Journal of Thoracic Oncology. 12, 10, p. 1588-1594 7 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component

Yang, J. C. H., Ahn, M. J., Kim, D. W., Ramalingam, S. S., Sequist, L. V., Su, W. C., Kim, S. W., Kim, J. H., Planchard, D., Felip, E., Blackhall, F., Haggstrom, D., Yoh, K., Novello, S., Gold, K., Hirashima, T., Lin, C. C., Mann, H., Cantarini, M., Ghiorghiu, S. & 1 others, Jänne, P. A., 2017 Apr 20, In : Journal of Clinical Oncology. 35, 12, p. 1288-1296 9 p.

Research output: Contribution to journalArticle

241 Citations (Scopus)
23 Citations (Scopus)

Successful AZD9291 Therapy in Advanced Non–Small Cell Lung Cancer after Failure of HM61713

Chen, C. W., Kuo, C. W., Chen, Y. L., Ho, C. L., Su, W. C. & Lin, C. C., 2017 Jun, In : Journal of Thoracic Oncology. 12, 6, p. e72-e74

Research output: Contribution to journalLetter

3 Citations (Scopus)
7 Citations (Scopus)
3 Citations (Scopus)

Zero-valent iron based nanoparticles selectively inhibit cancerous cells through mitochondria-mediated autophagy

Shieh, D. B., Yang, L. X., Lee, W. T., Huang, K. J., Wu, Y. N., Su, W. C., Chen, D. H. & Tsang, B., 2017 Nov 21, 2017 IEEE 17th International Conference on Nanotechnology, NANO 2017. Institute of Electrical and Electronics Engineers Inc., p. 168-170 3 p. 8117431. (2017 IEEE 17th International Conference on Nanotechnology, NANO 2017).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)
2018
Open Access
1 Citation (Scopus)
6 Citations (Scopus)

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

ATLANTIC Investigators, 2018 Apr, In : The Lancet Oncology. 19, 4, p. 521-536 16 p.

Research output: Contribution to journalArticle

159 Citations (Scopus)
7 Citations (Scopus)

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

John, T., Akamatsu, H., Delmonte, A., Su, W. C., Lee, J. S., Chang, G. C., Huang, X., Jenkins, S. & Wu, Y. L., 2018 Dec, In : Lung Cancer. 126, p. 133-138 6 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Electric Field–Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment

Wei, F., Strom, C. M., Cheng, J., Lin, C. C., Hsu, C. Y., Soo Hoo, G. W., Chia, D., Kim, Y., Li, F., Elashoff, D., Grognan, T., Tu, M., Liao, W., Xian, R., Grody, W. W., Su, W. C. & Wong, D. T. W., 2018 Nov, In : Journal of Molecular Diagnostics. 20, 6, p. 738-742 5 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy

Yen, C. C., Su, H. C., Chu, C. Y., Lai, S. J., Yan, J. J., Su, W. P. & Su, W. C., 2018 Jun, In : Lung Cancer. 120, p. 149-151 3 p.

Research output: Contribution to journalLetter

Osimertinib in untreated EGFR-Mutated advanced non-small-cell lung cancer

Soria, J. C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., Lee, K. H., Dechaphunkul, A., Imamura, F., Nogami, N., Kurata, T., Okamoto, I., Zhou, C., Cho, B. C., Cheng, Y., Cho, E. K., Voon, P. J., Planchard, D., Su, W. C., Gray, J. E., Lee, S. M. & 4 others, Hodge, R., Marotti, M., Rukazenkov, Y. & Ramalingam, S. S., 2018 Jan 11, In : New England Journal of Medicine. 378, 2, p. 113-125 13 p.

Research output: Contribution to journalArticle

1000 Citations (Scopus)

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer

Wu, Y. L., Zhang, L., Kim, D. W., Liu, X., Lee, D. H., Yang, J. C. H., Ahn, M. J., Vansteenkiste, J. F., Su, W. C., Felip, E., Chia, V., Glaser, S., Pultar, P., Zhao, S., Peng, B., Akimov, M. & Tan, D. S. W., 2018 Nov 1, In : Journal of Clinical Oncology. 36, 31, p. 3101-3109 9 p.

Research output: Contribution to journalArticle

63 Citations (Scopus)
6 Citations (Scopus)
4 Citations (Scopus)

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

Gerber, D. E., Horn, L., Boyer, M., Sanborn, R., Natale, R., Palmero, R., Bidoli, P., Bondarenko, I., Germonpre, P., Ghizdavescu, D., Kotsakis, A., Lena, H., Losonczy, G., Park, K., Su, W. C., Tang, M., Lai, J., Kallinteris, N. L., Shan, J. S., Reck, M. & 1 others, Spigel, D. R., 2018 Jul 1, In : Annals of Oncology. 29, 7, p. 1548-1553 6 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)
10 Citations (Scopus)
2019

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

Lin, C. C., Arkenau, H. T., Lu, S., Sachdev, J., de Castro Carpeño, J., Mita, M., Dziadziuszko, R., Su, W. C., Bobilev, D., Hughes, L., Chan, J., Zhang, Z. Y. & Weiss, G. J., 2019 Jul 16, In : British Journal of Cancer. 121, 2, p. 131-138 8 p.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)
Open Access
1 Citation (Scopus)
Open Access
2 Citations (Scopus)